Tanabe Atsushi, Egashira Yukari, Fukuoka Shin-Ichi, Shibata Katsumi, Sanada Hiroo
Graduate School of Science and Technology, Chiba University, 648 Matsudo, Chiba 271-8510, Japan.
J Nutr. 2002 Jun;132(6):1153-9. doi: 10.1093/jn/132.6.1153.
In the tryptophan-niacin conversion, 2-amino-3-carboxymuconate-6-semiardehyde decarboxylase (ACMSD; formerly termed picolinic carboxylase) is an important enzyme regulating the generation of quinolinate. In a series of experiments, we investigated alterations of ACMSD expression in rats by feeding a high protein diet and by inducing diabetes with streptozotocin (STZ). Male Sprague-Dawley rats (5-wk-old) were fed a diet containing 40% casein for 11 d, and hepatic ACMSD activity and mRNA expression were determined at intervals. The enzyme activity had increased at d 2, and it continued to increase through d 11. ACMSD mRNA expression had increased at d 1 and the elevated levels were maintained through d 11. Shifting from the 40% casein diet to a 20% casein diet restored hepatic ACMSD activity and mRNA expression to normal levels within 5 d and 2 d, respectively. In another series of experiments, male Wistar rats were injected with STZ (50 mg/kg) and the time-course (d 0, 1, 2, 4, 8 and 14) of the change in hepatic ACMSD activity and mRNA expression were examined. The activity increased dramatically after d 4, while mRNA expression was significantly elevated at d 2, followed by slight increases through d 14. Insulin administration (2 U/12 h) reduced the elevated ACMSD activity and fully suppressed the elevated ACMSD mRNA expression due to STZ injection. These results indicated that the fluctuation of hepatic ACMSD mRNA expression was followed by that of ACMSD activity.
在色氨酸-烟酸转化过程中,2-氨基-3-羧基粘康酸-6-半醛脱羧酶(ACMSD;以前称为吡啶甲酸羧化酶)是调节喹啉酸生成的一种重要酶。在一系列实验中,我们通过给大鼠喂食高蛋白饮食以及用链脲佐菌素(STZ)诱导糖尿病,研究了大鼠体内ACMSD表达的变化。将雄性Sprague-Dawley大鼠(5周龄)喂食含40%酪蛋白的饮食11天,并定期测定肝脏ACMSD活性和mRNA表达。酶活性在第2天增加,并持续增加至第11天。ACMSD mRNA表达在第1天增加,且升高水平维持至第11天。从40%酪蛋白饮食转换为20%酪蛋白饮食后,肝脏ACMSD活性和mRNA表达分别在5天和2天内恢复到正常水平。在另一系列实验中,给雄性Wistar大鼠注射STZ(50 mg/kg),并检测肝脏ACMSD活性和mRNA表达变化的时间进程(第0、1、2、4、8和14天)。第4天后活性急剧增加,而mRNA表达在第2天显著升高,随后至第14天略有增加。注射胰岛素(2 U/12 h)降低了因STZ注射导致的ACMSD活性升高,并完全抑制了ACMSD mRNA表达的升高。这些结果表明,肝脏ACMSD mRNA表达的波动伴随着ACMSD活性的波动。